Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
4CPS-114 Integration of a pharmacist into a geriatric departmentEuropean journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A67-A68 [Peer Reviewed Journal]European Association of Hospital Pharmacists 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 European Association of Hospital Pharmacists 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 2047-9956 ;EISSN: 2047-9964 ;DOI: 10.1136/ejhpharm-2022-eahp.142Full text available |
|
2 |
Material Type: Article
|
5PSQ-149 Durvalumab for the treatment of non-small cell lung cancer: real-world experienceEuropean journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A164-A165 [Peer Reviewed Journal]European Association of Hospital Pharmacists 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 European Association of Hospital Pharmacists 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 2047-9956 ;EISSN: 2047-9964 ;DOI: 10.1136/ejhpharm-2022-eahp.346Full text available |
|
3 |
Material Type: Article
|
4CPS-112 Adherence to adalimumab, golimumab and ustekinumab therapy in inflammatory bowel diseaseEuropean journal of hospital pharmacy. Science and practice, 2020-03, Vol.27 (Suppl 1), p.A100-A100 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 2047-9956 ;EISSN: 2047-9964 ;DOI: 10.1136/ejhpharm-2020-eahpconf.213Full text available |
|
4 |
Material Type: Article
|
4CPS-102 Influence of palbociclib toxicity in real world clinical practiceEuropean journal of hospital pharmacy. Science and practice, 2020-03, Vol.27 (Suppl 1), p.A95-A95 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 2047-9956 ;EISSN: 2047-9964 ;DOI: 10.1136/ejhpharm-2020-eahpconf.203Full text available |
|
5 |
Material Type: Article
|
5PSQ-050 Successful desensitisation in a patient with dasatinib hypersensitivityEuropean journal of hospital pharmacy. Science and practice, 2020-03, Vol.27 (Suppl 1), p.A172-A172 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 2047-9956 ;EISSN: 2047-9964 ;DOI: 10.1136/ejhpharm-2020-eahpconf.367Full text available |
|
6 |
Material Type: Article
|
4CPS-127 Economic impact of intensification regimens in inflammatory bowel diseaseEuropean journal of hospital pharmacy. Science and practice, 2020-03, Vol.27 (Suppl 1), p.A107-A107 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 2047-9956 ;EISSN: 2047-9964 ;DOI: 10.1136/ejhpharm-2020-eahpconf.228Full text available |
|
7 |
Material Type: Article
|
4CPS-360 Risk of malnutrition in patients with COVID-19 disease who receive oral nutritional supplementsEuropean journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A94-A94 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 2047-9956 ;EISSN: 2047-9964 ;DOI: 10.1136/ejhpharm-2021-eahpconf.192Full text available |